| Financial Year |
March 31 2023 |
| Monetary Funds |
1,173,563,250.04 |
| Held-for-trading Financial Assets |
7,100,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
60,167,212.94 |
| Advances to Suppliers |
15,794,793.57 |
| Other Receivables |
14,795,109.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,731,506.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
56,045,527.78 |
| Other Current Assets |
8,695,912.24 |
| Total Current Assets |
1,341,893,312.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
43,525,206.03 |
| Investment Properties |
-- |
| Fixed Assetes |
179,065,738.32 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,102,573.61 |
| R&D expenses |
-- |
| Goodwill |
227,601,550.70 |
| Long-Term Deferred and Prepaid Expenses |
24,161,102.14 |
| Deferred Income Tax Assets |
25,018,136.57 |
| Other Non-Current Assets |
60,193,339.77 |
| Sub-Total of Non-Current Assets |
963,893,119.31 |
| Total Assets |
2,305,786,431.89 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
83,986,368.85 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
39,602,641.69 |
| Taxes Payable |
13,765,001.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
89,437,995.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,984,076.15 |
| Other Current Liabilities |
6,047,191.06 |
| Sub-Total of Current Liabilities |
339,845,446.16 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
90,000.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
26,140,177.93 |
| Total Liabilities |
365,985,624.09 |
| Paid-In Capital(Or Share Stock) |
694,287,240.00 |
| Capital Surplus |
288,896,197.79 |
| Surplus Reserve |
213,135,350.42 |
| LESS:Treasury Stock |
321,062,596.18 |
| Undistributed Profits |
1,125,947,374.85 |
| Minority Stockholder's Interest |
56,903,108.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,882,897,699.39 |
| Owner's Equity（Stockholder's Equity） |
1,939,800,807.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,305,786,431.89 |
